OncologyTube.com is the first and only free video sharing website dedicated to helping oncology professionals spread knowledge about cancer research through video, audio and other multimedia.
    • OncologyTube Cancer Articles, News and Videos

      Site: OncologyTube Cancer Articles, News and Videos

    • 0
      • Portuguese
      • Spanish
      • Italian
      • Greek (Greece)
      • Sinhala
      • Polish
      • Arabic (Saudi Arabia)
      • Swedish (Sweden)
      • Portuguese (Brazil)
      • Hindi (India)
      • English (Australia)
      • Hebrew (Israel)
      • Czech
      • Hungarian (Hungary)
      • Chinese
      • Turkish
      • Japanese (Japan)
      • Dutch
      • French
      • German
      • Chinese (Traditional Han, Taiwan)
      • Korean (South Korea)
      • Thai
      • Spanish (Chile)
      • English (United States)
      • Russian
      • Danish (Denmark)
  • Home
  • Trending

  • Login

  • Quick Links
  • How To Self Record An Interview and Presentations
  • Schedule A Remote Interview!
  • Check Out Our Blog
  • Buy Advertising Banners
  • Buy Pre-Roll Advertisements
  • Boost Your Earned Media starting at Just $60
  • Create A Deep Dive Conversation
  • Advertising Specifications
  • Our Editorial Process
  • Publisher Calendar

  • Products & Pricing
  • Banner Advertising Plans
  • eNewsletter Packages
  • Pre-Roll Advertising
  • Create A Deep Dive Conversation
  • Create a Video Release (VR)
  • Boost Earned Media Only $60

  • Mobile
  • Connect Mobile App

  • Audio and Video
  • Videos
  • Audio

  • Channels
  • Browse Channels

  • Categories
  • Acute Lymphoblastic Leukemia 5595
  • Acute Myelogenous Leukemia 226
  • Bladder 96
  • Bone Metastases 5
  • Brain 79
  • Breast 562
  • Business Management 5
  • Cervical 16
  • Chronic Lymphocytic Leukemia 209
  • Chronic Myelogenous Leukemia 54
  • Colorectal 172
  • Conference Coverage 1
  • COVID-19 43
  • Gastrointestinal 177
  • General 341
  • Genitourinary 3
  • Head and Neck 110
  • Help 3
  • Hematologic Malignancies 206
  • Hodgkin Lymphoma 34
  • Imaging 2
  • Immunotherapy 179
  • Kidney 392
  • Liver 40
  • Lung 95
  • Lymphoma 235
  • Melanoma and Skin 107
  • Multiple Myeloma 535
  • Myeloproliferative Disease 37
  • News 149
  • Non-Hodgkin Lymphoma 81
  • Non-Small Cell Lung Cancer 554
  • Other 517
  • Ovarian 65
  • Pancreatic 104
  • Patient Resources 51
  • Pediatric 7
  • Prostate 300
  • Sarcoma 13
  • Sickle Cell 22
  • Small Cell Lung Cancer 81
  • Supportive Care 51
  • Testicular 3
  • Urology 16
  • Uterine 9

  • Install
  • Play a Link
  • About
  • Contact
  • Acute Lymphoblastic Leukemia
  • Acute Myelogenous Leukemia
  • Bladder
  • Bone Metastases
  • Brain
  • Breast
  • Business Management
  • Cervical
  • Chronic Lymphocytic Leukemia
  • Chronic Myelogenous Leukemia
  • Colorectal
  • Conference Coverage
  • COVID-19
  • Gastrointestinal
  • General
  • Genitourinary
  • Head and Neck
  • Help
  • Hematologic Malignancies
  • Hodgkin Lymphoma
  • Imaging
  • Immunotherapy
  • Kidney
  • Liver
  • Lung
  • Lymphoma
  • Melanoma and Skin
  • Multiple Myeloma
  • Myeloproliferative Disease
  • News
  • Non-Hodgkin Lymphoma
  • Non-Small Cell Lung Cancer
  • Other
  • Ovarian
  • Pancreatic
  • Patient Resources
  • Pediatric
  • Prostate
  • Sarcoma
  • Sickle Cell
  • Small Cell Lung Cancer
  • Supportive Care
  • Testicular
  • Urology
  • Uterine
Podcast - Richard A. Van Etten, MD @UCIrvineHealth @UCIrvine #LiverCancer #AASLD21 #CLiMBTrial #Cancer #Research Late-Breaking Positive Performance Data of HelioLiverâ„¢ for Early Liver C...
0:11:51

Podcast - Richard A. Van Etten, MD @UCIrvineHealth @UCIrv...

Richard A. Van Etten MD, Ph.D., Director of the NCI-designated Chao Family Comprehensive Cancer Center and member of the Division of Hematology/Oncology at the University of California, Irvine, Senior Associate Dean & Associate Vice Chancellor for Cancer University of California, Irvine speaks about Helio Health and Fulgent Genetics Announce Late-Breaking Positive Performance Data of HelioLiverâ„¢ for Early Liver Cancer Detection.

Link to Article:
https://www.prnewswire.com/news-releases/helio-health-and-fulgent-genetics-announce-late-breaking-positive-performance-data-of-helioliver-for-early-liver-cancer-detection-301418252.html


Helio Health and its commercial partner, Fulgent Genetics, Inc., presented fresh data at AASLD today proving the effectiveness of HelioLiver in detecting hepatocellular carcinoma in its early stages (HCC). HelioLiver's sensitivity was 76 percent in early-stage HCC and 85 percent in overall HCC1, exhibiting greater performance over alpha fetoprotein (AFP) alone and the GALAD model, with 91 percent specificity.

HelioLiver is a multi-analyte blood test that detects early-stage HCC with high accuracy using both cell-free DNA (cfDNA) methylation patterns and protein tumor markers. HelioLiver has the potential to improve morbidity and mortality in people with HCC since there are more curative therapy choices when the malignancy is detected early. A highly sensitive blood test can encourage patients to follow surveillance guidelines and make HCC detection more convenient and cost-effective.

The ENCORE study used blood samples from 303 people in a blinded, multicenter validation study. There were 122 people identified with HCC, 125 people diagnosed with benign liver disease, and 56 people diagnosed with other cancers in the study.

Beginning November 8, 2021, guests of The Liver Meeting® will be able to see a poster presentation titled "A Multi-Analyte Blood Test for Accurate and Early Detection of Hepatocellular Carcinoma."

In Helio's pivotal prospective trial, CLiMB, the HelioLiver test is still being reviewed (NCT: 03694600).

43 Views
1 year Ago
Cancer News
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

Liver

NRG / RTOG 1112 Phase 3 Trial: ASTRO [2022]
NRG / RTOG 1112 Phase 3 Trial: ASTRO [2022]
32 Views
4 months Ago
ASTRO
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
NRG / RTOG 1112 Phase 3 Trial: ASTRO [2022]
0:11:46
NRG / RTOG 1112 Phase 3 Trial: ASTRO [2022]
213 Views
4 months Ago
ASTRO
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
Rencofilstat in HCC: What You Need To Know
0:18:39
Rencofilstat in HCC: What You Need To Know
335 Views
7 months Ago
Cancer News
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
Podcast Mindie H. Nguyen, MD @Stanford @Stanford_GI #HelioLiver #LiverCancer ENCORE Data: HelioLiver For Liver Cancer
0:10:29
Podcast Mindie H. Nguyen, MD @Stanford @Stanford_GI #Heli...
64 Views
11 months Ago
Cancer News
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
Mindie H. Nguyen, MD @Stanford @Stanford_GI #HelioLiver #LiverCancer ENCORE Data: HelioLiver For Liver Cancer
0:10:29
Mindie H. Nguyen, MD @Stanford @Stanford_GI #HelioLiver #...
229 Views
11 months Ago
Cancer News
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
Podcast Professor Amit Singal @docamitgs @UTSWNews @utswcancer #HCC #LiverCancer Primary and Secondary Prevention: HCC
0:05:06
Podcast Professor Amit Singal @docamitgs @UTSWNews @utswc...
62 Views
1 year Ago
ESMO
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
Professor Amit Singal @docamitgs @UTSWNews @utswcancer #HCC #LiverCancer Primary and Secondary Prevention: HCC
0:05:06
Professor Amit Singal @docamitgs @UTSWNews @utswcancer #H...
35 Views
1 year Ago
ESMO
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
Podcast Daniel Rotroff, PhD @danielrotroff @FAucejo @ClevelandClinic #HCC #Biomarkers Salivary miRNAs As Non-invasive Biomarkers
0:07:40
Podcast Daniel Rotroff, PhD @danielrotroff @FAucejo @Clev...
21 Views
1 year Ago
Cancer News
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
Daniel Rotroff, PhD @danielrotroff @FAucejo @ClevelandClinic #HCC #Biomarkers Salivary miRNAs As Non-invasive Biomarkers
0:07:40
Daniel Rotroff, PhD @danielrotroff @FAucejo @ClevelandCli...
25 Views
1 year Ago
Cancer News
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
Podcast- Jerome Goldschmidt, MD- Understanding Hematological Adverse Event Management through Health Care Resource Utilization, Costs, and Treatment Patterns of Patients with Extensive-St...
0:11:55
Podcast- Jerome Goldschmidt, MD- Understanding Hematologi...
14 Views
1 year Ago
ASH
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
Jerome Goldschmidt, MD- Understanding Hematological Adverse Event Management through Health Care Resource Utilization, Costs, and Treatment Patterns of Patients with Extensive-Stage Small...
0:11:55
Jerome Goldschmidt, MD- Understanding Hematological Adver...
15 Views
1 year Ago
ASH
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login
Podcast - Richard A. Van Etten, MD @UCIrvineHealth @UCIrvine #LiverCancer #AASLD21 #CLiMBTrial #Cancer #Research Late-Breaking Positive Performance Data of HelioLiverâ„¢ for Early Liver C...
0:11:51
Podcast - Richard A. Van Etten, MD @UCIrvineHealth @UCIrv...
43 Views
1 year Ago
Cancer News
Add to
Want to watch this again later?
Sign in to add this video to a playlist. Login

comments@oncologytube.com Copyright 2023 Medicus Networks, Inc. 45121 Morgan Heights Rd. Temecula, CA 92592 - (951) 326-8827